INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-7.99 | ₹10.68 | ₹15.44 | ₹16.80 | ₹10.10 |
What is the latest Earnings Per Share (EPS) of INDOCO REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹-7.99 |
| Mar2024 | ₹10.68 |
| Mar2023 | ₹15.44 |
| Mar2022 | ₹16.80 |
| Mar2021 | ₹10.10 |
How is Earnings Per Share (EPS) of INDOCO REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.99 | Negative | |
| Mar2024 | ₹10.68 | -30.83 | |
| Mar2023 | ₹15.44 | -8.10 | |
| Mar2022 | ₹16.80 | 66.34 | |
| Mar2021 | ₹10.10 | - | |
Compare Earnings Per Share (EPS) of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,038.4 Cr | -1.1% | -15.1% | -28.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.1% |
-15.1% |
-28.4% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses